ArticleAesthetic surgery journal2026
A Comparative Study to Evaluate the Safety and Efficacy of Microneedling as a Stand-Alone Treatment for Striae Rubrae and Albae.
Article in Aesthetic surgery journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundStriae distensae are a common and often emotionally distressing dermatologic condition among adults. While therapeutic modalities are available, none completely resolve the visual or morphological changes of stretch marks.
objectivesThis study sought to evaluate the safety and efficacy of microneedling as a stand-alone treatment for both immature (striae rubrae) and mature (striae albae) stretch marks.
methodsFifteen striae rubrae and 19 striae albae regions from 29 subjects received 4 microneedling treatments, spaced monthly. Site-matched regions on opposite sides of the body were evaluated as untreated controls. Manchester Scar Scale (MSS) and Clinician's Global Aesthetic Improvement Assessment Scale (CGAIS) assessments were completed at all visits including follow-up at 3- and 6-months post-last microneedling treatment. Secondary endpoints included length measurements, adverse event monitoring, safety assessments, post-procedure symptom severity, and subject satisfaction.
resultsBoth striae rubrae and striae albae showed progressive improvements in clinical assessments across visits, including continued improvement between 3- and 6-months posttreatment. When comparing groups, striae rubrae had superior aesthetic outcomes, including 43.89% and 48.89% MSS score improvements over baseline at 3 and 6 months, respectively, compared with 36.69% and 41.61% for striae albae. While post-procedure reactions were also heightened for striae rubrae, all reactions were transient, and no adverse events were reported.
conclusionsThis study supports microneedling as a safe and effective treatment for striae rubrae and striae albae, offering preliminary evidence that intervening with microneedling in early-stage stretch marks (striae rubrae) can yield better cosmetic outcomes compared to mature stretch marks (striae albae). LEVEL OF EVIDENCE 3 (THERAPEUTIC):
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.